BriaCell Therapeutics BCTX
NASDAQ BCTX
$4.08 -0.08 (-1.81%)
At close: Sep 29, 2026 · 4:00 PM EDT

BriaCell Therapeutics (BCTX) Receivables - Other (2022 - 2025)

Updated

BriaCell Therapeutics (BCTX) posted Receivables - Other of $119,009 for fiscal Q4 2025 (quarter ended Jul 31, 2025), down 74.9% from $473,330 a year earlier.

Analysis

BriaCell Therapeutics (BCTX) Receivables - Other (2022 - 2025) Analysis & Trends

Since fiscal Q4 2022, BriaCell Therapeutics has reported Receivables - Other for 4 quarters.

  • Annual Receivables - Other shows a three-year compound annual growth rate of 16.4% (FY2022 to FY2025).
  • In prior fiscal years, BriaCell Therapeutics' Receivables - Other was $473,330 in FY2024, $40,753 in FY2023 (-46.1%) and $75,558 in FY2022.
  • The fiscal Q4 2025 figure stands as the lowest quarterly Receivables - Other since fiscal Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 BriaCell Therapeutics 30.16 Mn 29.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2025 119,009.00
Jul 31, 2024 473,330.00
Jul 31, 2023 40,753.00
Jul 31, 2022 75,558.00
API Access

BriaCell Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=BCTX&period=max&api_key=YOUR_API_KEY